Tamper-Resistant Drug Regulations
CPhA welcomes Health Canada’s announcement to seek stakeholder feedback on draft Tamper-Resistant Properties of Drugs Regulations. The draft regulations would require that all controlled release oxycodone products have tamper-resistant properties before they can be sold in Canada.